Comparison of the Efficacy & Tolerability of T1210 & Olopatadine

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The aim of this study is to compare the efficacy and the safety of T1210 versus Olopatadine eye drops in the topical treatment of seasonal allergic conjunctivitis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01344083
Study type	Interventional
Source	Laboratoires Thea
Contact
Status	Completed
Phase	Phase 2
Start date	April 2011
Completion date	February 2012

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05591755` - Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis	Phase 3
	Withdrawn	`NCT01541904` - Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis	Phase 2
	Completed	`NCT06212973` - A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients	Phase 3
	Completed	`NCT01435460` - Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)	Phase 3
	Completed	`NCT01342601` - Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents	N/A
	Completed	`NCT00133627` - Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis	Phase 4